Thyroid Disease

  • Eve M. LakeEmail author
  • Jennifer R. Lyden
  • Jeanie C. Yoon


Thyroid gland disorders are common. Because the thyroid regulates many critical systems within the body—including the cardiovascular, respiratory, renal, gastrointestinal, and hematologic systems—the main goal of perioperative management for patients with thyroid disease is to maintain a euthyroid state. Patients with clinically significant moderate and severe uncontrolled hypothyroidism or hyperthyroidism are at risk of perioperative complications; ideally, elective surgery would be deferred until a euthyroid state is achieved, but in the case of urgent surgery, it is crucial that these patients initiate treatment as soon as possible and are closely monitored for potential complications.


Hypothyroidism Hyperthyroidism Thyroid disease Perioperative Preoperative 



Bradley Anawalt, MD. Professor, Department of Medicine, Division of General Internal Medicine, University of Washington,


  1. 1.
    Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122(9):3035–43.CrossRefGoogle Scholar
  2. 2.
    Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.CrossRefGoogle Scholar
  3. 3.
    Werner SC, Ingbar SH, Braverman LE, Utiger RD. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.Google Scholar
  4. 4.
    Palace MR. Perioperative management of thyroid dysfunction. Health Serv Insights. 2017;10:1178632916689677. Open image in new windowCrossRefGoogle Scholar
  5. 5.
    Taylor PN, Razvi S, Pearce SH, Dayan CM. Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013;98(9):3562–71.CrossRefGoogle Scholar
  6. 6.
    Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028.CrossRefGoogle Scholar
  7. 7.
    Schiff RL, Welsh GA. Perioperative evaluation and management of the patient with endocrine dysfunction. Med Clin North Am. 2003;87(1):175–92.CrossRefGoogle Scholar
  8. 8.
    Dickerson RN, Maish GO 3rd, Minard G, Brown RO. Clinical relevancy of the levothyroxine-continuous enteral nutrition interaction. Nutr Clin Pract. 2010;25(6):646–52.CrossRefGoogle Scholar
  9. 9.
    Manessis A, Lascher S, Bukberg P, et al. Quantifying amount of adsorption of levothyroxine by percutaneous endoscopic gastrostomy tubes. JPEN J Parenter Enteral Nutr. 2008;32(2):197–200.CrossRefGoogle Scholar
  10. 10.
    Weinberg AD, Brennan MD, Gorman CA, Marsh HM, O’Fallon WM. Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med. 1983;143(5):893–7.CrossRefGoogle Scholar
  11. 11.
    Gualandro DM, Pinho C, et al. I Guidelines for perioperative evaluation. Arq Bras Cardiol. 2007;89(6):210–37.CrossRefGoogle Scholar
  12. 12.
    Stathatos N, Wartofsky L. Perioperative management of patients with hypothyroidism. Endocrinol Metab Clin N Am. 2003;32(2):503–18.CrossRefGoogle Scholar
  13. 13.
    Graham GW, Unger BP, Coursin DB. Perioperative management of selected endocrine disorders. Int Anesthesiol Clin. 2000;38(4):31–67.CrossRefGoogle Scholar
  14. 14.
    Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 2002;12(10):839–47.CrossRefGoogle Scholar
  15. 15.
    Murkin JM. Anesthesia and hypothyroidism: a review of thyroxine physiology, pharmacology, and anesthetic implications. Anesth Analg. 1982;61(4):371–83.CrossRefGoogle Scholar
  16. 16.
    Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007;22(4):224–31.CrossRefGoogle Scholar
  17. 17.
    Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am. 2012;96(2):385–403.CrossRefGoogle Scholar
  18. 18.
    Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000;62(11):2485–90.PubMedGoogle Scholar
  19. 19.
    Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM, American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–1751. Open image in new windowCrossRefGoogle Scholar
  20. 20.
    Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clin Chem. 1996;42(1):188–92.PubMedGoogle Scholar
  21. 21.
    Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev. 1982;3(2):164–217.CrossRefGoogle Scholar
  22. 22.
    DeGroot LJ. “Non-thyroidal illness syndrome” is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge. J Endocrinol Investig. Dec 2003;26(12):1163–70.CrossRefGoogle Scholar
  23. 23.
    Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin N Am. 2007;36(3):657–72, vi.CrossRefGoogle Scholar
  24. 24.
    Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35.CrossRefGoogle Scholar
  25. 25.
    Arlot S, Debussche X, Lalau JD, et al. Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med. 1991;17(1):16–8.CrossRefGoogle Scholar
  26. 26.
    Yamamoto T, Fukuyama J, Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid. 1999;9(12):1167–74.CrossRefGoogle Scholar
  27. 27.
    Guden M, Akpinar B, Saggbas E, Sanisoglu I, Cakali E, Bayindir O. Effects of intravenous triiodothyronine during coronary artery bypass surgery. Asian Cardiovasc Thorac Ann. 2002;10(3):219–22.CrossRefGoogle Scholar
  28. 28.
    Hamilton MA, Stevenson LW, Fonarow GC, et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol. 1998;81(4):443–7.CrossRefGoogle Scholar
  29. 29.
    Sawin CT, Geller A. Low serum thyrotropic concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.CrossRefGoogle Scholar
  30. 30.
    Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D’Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.CrossRefGoogle Scholar
  31. 31.
    Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033–41.CrossRefGoogle Scholar
  32. 32.
    Langley RW, Burch HB. Perioperative management of the thyrotoxic patient. Endocrinol Metab Clin N Am. 2003;32:519.CrossRefGoogle Scholar
  33. 33.
    Adlerberth A, Stenström G, Hasselgren PO. The selective beta 1-blocking agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Results from a prospective, randomized study. Ann Surg. 1987;205(2):182.CrossRefGoogle Scholar
  34. 34.
    Woeber KA. Thyrotoxicosis and the heart. N Engl J Med. 1992;372(2):94.Google Scholar
  35. 35.
    Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004;164(15):1675.CrossRefGoogle Scholar
  36. 36.
    Mercé J, Ferrás S, Oltra C, Sanz E, Vendrell J, Simón I, Camprubí M, Bardají A, Ridao C. Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. Am J Med. 2005;118(2):126.CrossRefGoogle Scholar
  37. 37.
    Siu CW, Zhang XH, Yung C, Kung AW, Lau CP, Tse HF. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol Metab. 2007;92(5):1736.CrossRefGoogle Scholar
  38. 38.
    Das G, Krieger M. Treatment of thyrotoxic storm with intravenous administration of propranolol. Ann Intern Med. 1969;70(5):985.CrossRefGoogle Scholar
  39. 39.
    Ross DS. Iodinated radiocontrast agents in the treatment of hyperthyroidism. UpToDate. 2013.Google Scholar
  40. 40.
    Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am. 1993;22(2):263.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Eve M. Lake
    • 1
    Email author
  • Jennifer R. Lyden
    • 2
  • Jeanie C. Yoon
    • 3
  1. 1.Department of Medicine, Division of General Internal MedicineUniversity of WashingtonSeattleUSA
  2. 2.Department of Medicine, Division of Hospital MedicineDenver HealthDenverUSA
  3. 3.Department of Medicine, Division of Hospital MedicineVirginia Hospital CenterArlingtonUSA

Personalised recommendations